| 发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR A DPP-I V INHIBITOR AND OPTIONALLY A FURTHER ANTIDIABETIC AGENT AND USES THEREOF |
| 摘要 |
<p>The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.</p> |
| 申请公布号 |
TN2011000415(A1) |
申请公布日期 |
2013.03.27 |
| 申请号 |
TN20110000415 |
申请日期 |
2011.08.12 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
EICKELMANN PETER;MARK MICHAEL;SEMAN LEO JOHN;THOMAS LEO;BROEDL ULI;GREMPLER ROLF |
| 分类号 |
A61K31/00;A61K31/06;A61K31/155;A61K31/198;A61K31/341;A61K31/351;A61K31/39;A61K31/403;A61K31/4439;A61K31/70;A61K31/7004;A61K31/7008;A61P3/06;A61P3/08;A61P3/10 |
主分类号 |
A61K31/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
